13F Holdings
中文EN

TCMD TACTILE SYSTEMS TECHNOLOGY INC

Surgical & Medical Instruments & Apparatus · Nasdaq · SEC CIK 1027838 · Fiscal year ends 12/31

Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters

Growth

TTM revenue YoY14.4%
TTM net income YoY31.1%
TTM EPS YoY35.5%
Revenue 3-yr CAGR9.6%
Net income 3-yr CAGR-1.5%

Margins

Gross margin77.0%
Operating margin9.4%
Net margin6.7%
FCF margin8.1%
EBITDA margin11.4%

Returns

ROE11.0%
ROA8.7%
ROIC (approx.)15.3%
Asset turnover1.29x

Leverage & solvency

Liabilities / assets22.0%
Debt / equity0.00x
Current ratio3.51x
Interest coverage431.51x

Cash quality & payout

Operating cash flow / net income1.35x
Accruals ratio-3.0%
Payout ratio—
Capex / revenue0.9%

Factor history charts and full statement history on Pro 🔒

Financial statements

Line item FY20252025-12-31FY20242024-12-31FY20232023-12-31FY20222022-12-31FY20212021-12-31
Income statement
Revenue$329.52M$292.98M$274.42M$246.78M$208.06M
Cost of revenue$79.38M$76.30M$79.29M$70.81M$59.84M
Gross profit$250.15M$216.69M$195.13M$175.98M$148.21M
R&D expense$8.48M$8.83M$7.82M$7.09M$5.66M
SG&A expense$88.70M$71.14M$62.07M$60.80M$56.80M
Operating income$29.28M$22.18M$18.04M-$12.76M-$1.76M
Interest expense$1.04M$2.08M$4.15M$2.79M—
Pretax income$31.34M$23.49M$15.77M-$15.47M-$2.29M
Income tax$12.25M$6.53M-$12.74M$2.39M$9.52M
Net income$19.09M$16.96M$28.52M-$17.87M-$11.81M
EBITDA$35.92M$28.97M$24.58M-$6.49M$1.92M
EPS (basic)0.830.711.24-0.89-0.60
EPS (diluted)0.820.701.23-0.89-0.60
Weighted avg. shares (diluted)23.30M24.14M23.18M20.07M19.72M
Balance sheet
Cash & equivalents$83.45M$94.37M$61.03M$21.93M$28.23M
Receivables$43.88M$44.94M$43.17M$54.83M$49.48M
Inventory$14.03M$18.67M$22.53M$23.12M$19.22M
Current assets$165.17M$177.56M$145.29M$119.76M$113.55M
PP&E, net$5.12M$5.60M$6.20M$6.08M$6.75M
Goodwill$31.06M$31.06M$31.06M$31.06M$31.06M
Intangibles$39.17M$42.79M$46.72M$50.38M$54.08M
Total assets$273.94M$297.92M$281.44M$255.00M$244.27M
Current liabilities$40.96M$40.70M$41.06M$64.33M$34.46M
Long-term debt$0————
Total debt$0————
Total liabilities$55.04M$81.33M$87.80M$133.60M$116.04M
Shareholders' equity$218.90M$216.60M$193.64M$121.40M$128.23M
Net debt-$83.45M————
Shares outstanding22.44M23.88M23.60M20.25M19.88M
Cash flow statement
Operating cash flow$42.81M$40.66M$35.85M$5.21M$2.63M
Capital expenditure$2.38M$2.39M$2.32M$1.78M$2.10M
Free cash flow$40.43M$38.26M$33.53M$3.43M$528,000
Investing cash flow-$2.54M-$2.50M-$2.48M-$1.91M-$82.18M
Financing cash flow-$51.20M-$4.82M$5.73M-$9.60M$59.93M
Depreciation & amortization$6.64M$6.79M$6.54M$6.27M$3.68M
Stock-based compensation$8.36M$7.82M$7.55M$9.60M$10.17M
Share buybacks$26.56M$3.51M———

Free plan shows the latest 5 periods; Pro shows all 12 🔒

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-18 06:30.